Find Hydroxyethyl Starch manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

0

JDMF

0

EU WC

0

NDC API

0

VMF

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

0

Canada

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 9005-27-0, Starch, 2-hydroxyethyl ether, 2-hydroxyethyl starch, (2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;2-[[(2r,3r,4s,5r,6s)-3,4,5,6-tetrakis(2-hydroxyethoxy)oxan-2-yl]methoxy]ethanol, Hydroxyethyl starch 130/0.4, Starch, 2-hydroxyethyl ether, base-hydrolyzed
Molecular Formula
C22H44O17
Molecular Weight
580.6  g/mol
InChI Key
DNZMDASEFMLYBU-RNBXVSKKSA-N

Hydroxyethyl Starch
Hydroxyethyl starch (HES/HAES) is a nonionic starch derivative. Hydroxyethyl starches (HES) are synthetic colloids commonly used for fluid resuscitation to replace intravascular volume. HES is a general term and can be sub-classified according to average molecular weight, molar substitution, concentration, C2/C6 ratio and Maximum Daily Dose.
1 2D Structure

Hydroxyethyl Starch

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;2-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis(2-hydroxyethoxy)oxan-2-yl]methoxy]ethanol
2.1.2 InChI
InChI=1S/C16H32O11.C6H12O6/c17-1-6-22-11-12-13(23-7-2-18)14(24-8-3-19)15(25-9-4-20)16(27-12)26-10-5-21;7-1-2-3(8)4(9)5(10)6(11)12-2/h12-21H,1-11H2;2-11H,1H2/t12-,13-,14+,15-,16+;2-,3-,4+,5-,6+/m11/s1
2.1.3 InChI Key
DNZMDASEFMLYBU-RNBXVSKKSA-N
2.1.4 Canonical SMILES
C(COCC1C(C(C(C(O1)OCCO)OCCO)OCCO)OCCO)O.C(C1C(C(C(C(O1)O)O)O)O)O
2.1.5 Isomeric SMILES
C(COC[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OCCO)OCCO)OCCO)OCCO)O.C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 9005-27-0

2. Starch, 2-hydroxyethyl Ether

3. 2-hydroxyethyl Starch

4. (2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;2-[[(2r,3r,4s,5r,6s)-3,4,5,6-tetrakis(2-hydroxyethoxy)oxan-2-yl]methoxy]ethanol

5. Hydroxyethyl Starch 130/0.4

6. Starch, 2-hydroxyethyl Ether, Base-hydrolyzed

7. 68512-26-5

8. Chembl1730764

9. Akos030254900

10. Hydroxyethyl Starch (high Mw), European Pharmacopoeia (ep) Reference Standard

11. Hydroxyethyl Starch (medium Mw), European Pharmacopoeia (ep) Reference Standard

2.3 Create Date
2007-07-12
3 Chemical and Physical Properties
Molecular Weight 580.6 g/mol
Molecular Formula C22H44O17
Hydrogen Bond Donor Count10
Hydrogen Bond Acceptor Count17
Rotatable Bond Count17
Exact Mass580.25784993 g/mol
Monoisotopic Mass580.25784993 g/mol
Topological Polar Surface Area267 Ų
Heavy Atom Count39
Formal Charge0
Complexity497
Isotope Atom Count0
Defined Atom Stereocenter Count10
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

An intravenous solution of hydroxyethyl starch is used to prevent shock following severe blood loss caused by trauma, surgery, or other issues.


5 Pharmacology and Biochemistry
5.1 Pharmacology

After isovolemic exchange of blood with 500 mL of HES in healthy volunteers, blood volume is maintained for at least 6 hours


5.2 Absorption, Distribution and Excretion

Absorption

Peak concentration (C(max), 4.34 mg/mL)


Route of Elimination

Approximately 62 % of HES was excreted as hydroxyethyl starch molecules in urine within 72 hours.


Volume of Distribution

5.9 L.


Clearance

31.4 mL/min


5.3 Metabolism/Metabolites

When given intravenously, molecules smaller than the renal threshold (60,000-70,000 daltons) are readily and rapidly excreted in the urine, while molecules with higher molecular weights are metabolized by plasma -amylase prior to excretion via the renal route.


5.4 Biological Half-Life

Terminal half-life is 16.1 h. Elimination half-life is 12 h.


5.5 Mechanism of Action

Hydroxyethyl starch (HES) is one of the most frequently used plasma substitutes. Recent studies have indicated that HES may reduce capillary leakage.


API SUPPLIERS

read-more
read-more

01

Swati Spentose

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Company Banner

02

WUHAN HUST LIFE SCI & TECH CO.,LTD

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

RDD
Not Confirmed
arrow

WUHAN HUST LIFE SCI & TECH CO.,LTD

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
RDD
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

Shandong Qidu Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

RDD
Not Confirmed
arrow

04

Fresenius Kabi Austria

Austria

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

RDD
Not Confirmed
arrow

Fresenius Kabi Austria

Austria

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
RDD
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

05

B. Braun Medical

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

RDD
Not Confirmed
arrow

B. Braun Medical

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
RDD
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

Flag India
Digital Content Digital Content

Hydroxyethyl Starch

About the Company : Swati Spentose Pvt. Ltd. (SSPL), part of the 60-year-old V Group, is a globally trusted pharmaceutical manufacturer supplying to 70+ countries. We specialize in high-quality APIs a...

Swati Spentose Pvt. Ltd. (SSPL), part of the 60-year-old V Group, is a globally trusted pharmaceutical manufacturer supplying to 70+ countries. We specialize in high-quality APIs and are forward-integrated into Finished Dosage Forms, offering end-to-end solutions. SSPL Unit 1 is USFDA inspected, EU-GMP, ANVISA, WHO-GMP, COFEPRIS, MFDS certified, AFM: AG12300239. SSPL Unit 2 is PMDA inspected and WHO-GMP, ANVISA certified. We look forward to exploring collaboration opportunities. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

02

RDD
Not Confirmed
arrow
arrow
RDD
Not Confirmed

Hydroxyethyl Starch

About the Company : Shandong Qidu Pharmaceutical is a comprehensive and research-based drug production enterprise which produces IV solutions, oral preparations, APIs and so on. The products mainly in...

Shandong Qidu Pharmaceutical is a comprehensive and research-based drug production enterprise which produces IV solutions, oral preparations, APIs and so on. The products mainly involve basic infusions, intravenous nutrition liquid, plasma substitutes, anti-infective agents, anti tumor drugs, cardio-cerebrovascular drugs, internal secretion regulators, pharmaceutical packaging materials, medical supplies and so on.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Volulyte (Hydroxyethyl Starch) is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hemorrhage.


Lead Product(s): Hydroxyethyl Starch,Inapplicable

Therapeutic Area: Hematology Brand Name: Volulyte

Study Phase: Phase IVProduct Type: Carbohydrate

Sponsor: B. Braun Medical | European Society of Anaesthesiology and Intensive Care

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 09, 2017

blank

01

RDD
Not Confirmed
RDD
Not Confirmed

Lead Product(s) : Hydroxyethyl Starch,Inapplicable

Therapeutic Area : Hematology

Highest Development Status : Phase IV

Partner/Sponsor/Collaborator : B. Braun Medical | European Society of Anaesthesiology and Intensive Care

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Volulyte (Hydroxyethyl Starch) is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hemorrhage.

Product Name : Volulyte

Product Type : Carbohydrate

Upfront Cash : Inapplicable

November 09, 2017

blank

Details:

Volulyte (Hydroxyethyl Starch) is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hemorrhage.


Lead Product(s): Hydroxyethyl Starch,Inapplicable

Therapeutic Area: Hematology Brand Name: Volulyte

Study Phase: Phase IVProduct Type: Carbohydrate

Sponsor: B. Braun Medical | European Society of Anaesthesiology and Intensive Care

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 11, 2017

blank

02

RDD
Not Confirmed
RDD
Not Confirmed

Lead Product(s) : Hydroxyethyl Starch,Inapplicable

Therapeutic Area : Hematology

Highest Development Status : Phase IV

Partner/Sponsor/Collaborator : B. Braun Medical | European Society of Anaesthesiology and Intensive Care

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Volulyte (Hydroxyethyl Starch) is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hemorrhage.

Product Name : Volulyte

Product Type : Carbohydrate

Upfront Cash : Inapplicable

September 11, 2017

blank

Details:

HES 130 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Postoperative Acute Kidney Injury.


Lead Product(s): HES 130,Hydroxyethyl Starch

Therapeutic Area: Nephrology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Undisclosed

Sponsor: Fresenius Kabi AB Brunna

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 16, 2014

blank

03

RDD
Not Confirmed
RDD
Not Confirmed

Details : HES 130 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Postoperative Acute Kidney Injury.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

July 16, 2014

blank

Details:

Hydroxyethyl Starch is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Heart Failure.


Lead Product(s): Hydroxyethyl Starch,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Carbohydrate

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 14, 2012

blank

04

RDD
Not Confirmed
RDD
Not Confirmed

Details : Hydroxyethyl Starch is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Heart Failure.

Product Name : Undisclosed

Product Type : Carbohydrate

Upfront Cash : Inapplicable

March 14, 2012

blank

Details:

Hydroxyethyl Starch is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.


Lead Product(s): Hydroxyethyl Starch,Inapplicable

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Carbohydrate

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 17, 2011

blank

05

RDD
Not Confirmed
RDD
Not Confirmed

Details : Hydroxyethyl Starch is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Carbohydrate

Upfront Cash : Inapplicable

August 17, 2011

blank

Details:

Hydroxyethyl Starch is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Blood Pressure Disorders.


Lead Product(s): Hydroxyethyl Starch,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Carbohydrate

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 23, 2011

blank

06

RDD
Not Confirmed
RDD
Not Confirmed

Details : Hydroxyethyl Starch is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Blood Pressure Disorders.

Product Name : Undisclosed

Product Type : Carbohydrate

Upfront Cash : Inapplicable

February 23, 2011

blank

Details:

Hydroxyethyl Starch is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hypovolemia.


Lead Product(s): Hydroxyethyl Starch,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Carbohydrate

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 21, 2010

blank

07

RDD
Not Confirmed
RDD
Not Confirmed

Details : Hydroxyethyl Starch is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hypovolemia.

Product Name : Undisclosed

Product Type : Carbohydrate

Upfront Cash : Inapplicable

May 21, 2010

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

RDD
Not Confirmed
arrow
RDD
Not Confirmed
arrow

CAS Number : 9005-27-0

End Use API : Hydroxyethyl Starch

About The Company : Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceu...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Looking for 9005-27-0 / Hydroxyethyl Starch API manufacturers, exporters & distributors?

Hydroxyethyl Starch manufacturers, exporters & distributors 1

47

PharmaCompass offers a list of Hydroxyethyl Starch API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Hydroxyethyl Starch manufacturer or Hydroxyethyl Starch supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydroxyethyl Starch manufacturer or Hydroxyethyl Starch supplier.

API | Excipient name

Hydroxyethyl Starch

Synonyms

9005-27-0, Starch, 2-hydroxyethyl ether, 2-hydroxyethyl starch, (2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;2-[[(2r,3r,4s,5r,6s)-3,4,5,6-tetrakis(2-hydroxyethoxy)oxan-2-yl]methoxy]ethanol, Hydroxyethyl starch 130/0.4, Starch, 2-hydroxyethyl ether, base-hydrolyzed

Cas Number

9005-27-0

About Hydroxyethyl Starch

Hydroxyethyl starch (HES/HAES) is a nonionic starch derivative. Hydroxyethyl starches (HES) are synthetic colloids commonly used for fluid resuscitation to replace intravascular volume. HES is a general term and can be sub-classified according to average molecular weight, molar substitution, concentration, C2/C6 ratio and Maximum Daily Dose.

Hydroxyethyl Starch Manufacturers

A Hydroxyethyl Starch manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxyethyl Starch, including repackagers and relabelers. The FDA regulates Hydroxyethyl Starch manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxyethyl Starch API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Hydroxyethyl Starch manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Hydroxyethyl Starch Suppliers

A Hydroxyethyl Starch supplier is an individual or a company that provides Hydroxyethyl Starch active pharmaceutical ingredient (API) or Hydroxyethyl Starch finished formulations upon request. The Hydroxyethyl Starch suppliers may include Hydroxyethyl Starch API manufacturers, exporters, distributors and traders.

click here to find a list of Hydroxyethyl Starch suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Hydroxyethyl Starch KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Hydroxyethyl Starch Drug Master File in Korea (Hydroxyethyl Starch KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hydroxyethyl Starch. The MFDS reviews the Hydroxyethyl Starch KDMF as part of the drug registration process and uses the information provided in the Hydroxyethyl Starch KDMF to evaluate the safety and efficacy of the drug.

After submitting a Hydroxyethyl Starch KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hydroxyethyl Starch API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Hydroxyethyl Starch suppliers with KDMF on PharmaCompass.

Hydroxyethyl Starch CEP

A Hydroxyethyl Starch CEP of the European Pharmacopoeia monograph is often referred to as a Hydroxyethyl Starch Certificate of Suitability (COS). The purpose of a Hydroxyethyl Starch CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hydroxyethyl Starch EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hydroxyethyl Starch to their clients by showing that a Hydroxyethyl Starch CEP has been issued for it. The manufacturer submits a Hydroxyethyl Starch CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hydroxyethyl Starch CEP holder for the record. Additionally, the data presented in the Hydroxyethyl Starch CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hydroxyethyl Starch DMF.

A Hydroxyethyl Starch CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hydroxyethyl Starch CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Hydroxyethyl Starch suppliers with CEP (COS) on PharmaCompass.

Hydroxyethyl Starch GMP

Hydroxyethyl Starch Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Hydroxyethyl Starch GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Hydroxyethyl Starch GMP manufacturer or Hydroxyethyl Starch GMP API supplier for your needs.

Hydroxyethyl Starch CoA

A Hydroxyethyl Starch CoA (Certificate of Analysis) is a formal document that attests to Hydroxyethyl Starch's compliance with Hydroxyethyl Starch specifications and serves as a tool for batch-level quality control.

Hydroxyethyl Starch CoA mostly includes findings from lab analyses of a specific batch. For each Hydroxyethyl Starch CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Hydroxyethyl Starch may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydroxyethyl Starch EP), Hydroxyethyl Starch JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydroxyethyl Starch USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty